Log in to save to my catalogue

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6340c56710a44b2f8ef9c6037233588b

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke

About this item

Full title

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke

Publisher

United States: Hindawi

Journal title

Neural plasticity, 2021, Vol.2021, p.6718184-9

Language

English

Formats

Publication information

Publisher

United States: Hindawi

More information

Scope and Contents

Contents

Several clinical parameters and biomarkers have been proposed as prognostic markers for stroke. However, it has not been clarified whether the risk factors affecting the prognosis of patients with recurrent and first-ever stroke are similar. In this study, we aimed to explore the relationship between soluble lectin-like oxidized low-density lipopro...

Alternative Titles

Full title

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6340c56710a44b2f8ef9c6037233588b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6340c56710a44b2f8ef9c6037233588b

Other Identifiers

ISSN

2090-5904

E-ISSN

1687-5443

DOI

10.1155/2021/6718184

How to access this item